Physician profile
Walter J Coyle
NPI 1609847482
$269,400.32
in general payments reported to CMS, 2019-2025
50 companies · $86K in 2025
The $86K reported for 2025 was more than what 98% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $345 · 2021: $27K · 2022: $13K · 2023: $61K · 2024: $66K · 2025: $86K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $176K · Travel and Lodging: $22K · Food and Beverage: $13K · Consulting Fee: $2,500 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $176,168.50 |
| Travel and Lodging | $22,018.54 |
| Food and Beverage | $12,647.15 |
| Consulting Fee | $2,500.00 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $160,722.19 | 2022-2025 | Dupixent |
| Abbvie INC. | $80,003.80 | 2019-2025 | Creon, Linzess, Rinvoq |
| Genzyme Corporation | $13,859.37 | 2019-2025 | |
| US Endoscopy | $2,500.00 | 2025 | |
| Csa Medical, INC | $2,212.10 | 2019 | |
| Steris Corporation | $1,552.57 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,144.39 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Pfizer INC. | $908.67 | 2019-2025 | |
| 3-D Matrix, INC. | $890.85 | 2025 | |
| Boston Scientific Corporation | $746.56 | 2019-2025 | Axios, Acquire, Therasphere Y90 Glass Microspheres 10 Gbq |
| Janssen Biotech, INC. | $707.78 | 2019-2025 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $608.09 | 2019-2025 | Xifaxan, Trulance |
| Aimmune Therapeutics, INC. | $369.95 | 2023-2025 | Zenpep, Vowst |
| Phathom Pharmaceuticals, INC. | $293.57 | 2024-2025 | Voquezna |
| Madrigal Pharmaceuticals | $290.09 | 2025 | Rezdiffra |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $286.55 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| Celgene Corporation | $236.86 | 2019-2023 | Zeposia |
| Olympus America INC. | $231.62 | 2021-2023 | Xenon Lamp, Evis Exera III Video System Center |
| Ferring Pharmaceuticals INC. | $216.06 | 2019-2024 | Rebyota |
| Intercept Pharmaceuticals, INC. | $208.27 | 2019-2024 | Ocaliva |
| Ardelyx, INC. | $156.25 | 2023-2025 | Ibsrela |
| Regeneron Pharmaceuticals, INC. | $150.01 | 2025 | Dupixent |
| Janssen Scientific Affairs, LLC | $124.99 | 2020 | |
| Vivus LLC | $124.97 | 2019-2025 | Qsymia |
| Ucb, INC. | $88.19 | 2019 | |
| Redhill Biopharma INC. | $72.86 | 2023-2024 | Talicia |
| Merit Medical Systems INC | $61.94 | 2024 | Endomaxx Stent and Delivery System, Alimaxx-B Stent/Del Sys |
| Pentax of America, INC. | $58.27 | 2021-2022 | |
| Qol Medical, LLC | $56.28 | 2019-2021 | |
| Braintree Laboratories, INC. | $53.88 | 2019-2021 | |
| Blueprint Medicines Corporation | $53.25 | 2023 | |
| Nestle Healthcare Nutrition INC. | $47.75 | 2023 | |
| Orphalan INC | $38.01 | 2024 | Cuvrior |
| Allergan, INC. | $34.81 | 2019 | |
| Taiho Oncology, INC. | $22.82 | 2023 | |
| Alexion Pharmaceuticals, INC. | $22.76 | 2020 | |
| Evoke Pharma, INC. | $22.67 | 2024 | |
| Capsovision, INC. | $22.58 | 2025 | Capsocam Plus |
| Alnylam Pharmaceuticals INC. | $20.48 | 2020 | |
| Ironwood Pharmaceuticals, INC | $19.18 | 2021 | |
| Shionogi INC | $19.06 | 2019 | |
| Eisai INC. | $19.03 | 2019 | |
| Laborie Medical Technologies Corp. | $18.48 | 2024 | Alphaone |
| Mallinckrodt Hospital Products INC. | $18.30 | 2022 | |
| Amgen INC. | $18.15 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.80 | 2020 | |
| Alfasigma USA, INC. | $14.66 | 2020 | |
| Celltrion USA INC. | $14.21 | 2025 | Vegzelma |
| Cook Medical LLC | $12.06 | 2019 | |
| Intra-Sana Laboratories | $10.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.